Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015717
Filing Date
2024-11-14
Accepted
2024-11-14 16:16:20
Documents
55
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpth-20240930x10q.htm   iXBRL 10-Q 943925
2 EX-10.3 bpth-20240930xex10d3.htm EX-10.3 49464
3 EX-31 bpth-20240930xex31.htm EX-31 12495
4 EX-32 bpth-20240930xex32.htm EX-32 6296
  Complete submission text file 0001558370-24-015717.txt   3973385

Data Files

Seq Description Document Type Size
5 EX-101.SCH bpth-20240930.xsd EX-101.SCH 32990
6 EX-101.CAL bpth-20240930_cal.xml EX-101.CAL 31835
7 EX-101.DEF bpth-20240930_def.xml EX-101.DEF 135403
8 EX-101.LAB bpth-20240930_lab.xml EX-101.LAB 250320
9 EX-101.PRE bpth-20240930_pre.xml EX-101.PRE 224505
58 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20240930x10q_htm.xml XML 423258
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS, INC. (Filer) CIK: 0001133818 (see all company filings)

EIN.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36333 | Film No.: 241462590
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)